EUVIMEDEUVIMED entdecken
Crossref

B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females

Charalampos Skarlis, Vassilis Papadopoulos, Sylvia Raftopoulou, Clio P Mavragani, Maria-Eleftheria Evangelopoulos

Clinical Immunology · 2023-12 · 257 · 109847

DOI: 10.1016/j.clim.2023.109847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2023-12. Verfasst von Charalampos Skarlis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, National and Kapodistrian University of Athens (NKUA), M. Asias 75, 11527, Athens, Greece. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Multiple Sclerosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although B cells and B cell activating factor (BAFF) have been previously implicated in MS pathogenesis, data regarding the genetic influence of BAFF polymorphisms on MS susceptibility are limited. Here we aim to explore whether BAFF polymorphisms could contribute to MS susceptibility. 156 RRMS patients fulfilling the revised McDonald criteria for MS diagnosis and 220 HCs were enrolled. Clinical, laboratory, and imaging characteristics were recorded. BAFF rs9514827, rs1041569, and rs9514828 polymorphisms were assessed by RFLP-PCR in DNA samples extracted from whole peripheral blood. The BAFF rs1041569 TT genotype along with the CTT and TTC haplotypes were associated with significantly increased risk for MS development in female MS patients compared to healthy female counterparts. These findings were not confirmed in males. The rs1041569 BAFF variant together with the CTT and TTC BAFF haplotypes derived from the BAFF rs9514827, rs1041569, and rs9514828 polymorphisms may represent novel genetic contributors to the development of MS in females.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseMultiple SclerosisFemaleHumansMaleB-Cell Activating FactorGene FrequencyGenotypePolymorphism, Single Nucleotide

Stichwörter der Autor:innen

B-cell activating factor (BAFF)Multiple sclerosis (MS)

Substanzen

B-Cell Activating FactorTNFSF13B protein, human

Autor:innen und Institutionen

  • Department of Physiology, School of Medicine, National and Kapodistrian University of Athens (NKUA), M. Asias 75, 11527, Athens, Greece.
  • First Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Physiology, School of Medicine, National and Kapodistrian University of Athens (NKUA), M. Asias 75, 11527, Athens, Greece; Joint Academic Rheumatology Program, NKUA, Greece. Electronic address: kmauragan@m…

Zitieren

APA

Skarlis, C., Papadopoulos, V., Raftopoulou, S., Mavragani, C. P., & Evangelopoulos, M. E. (2023). B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females. Clinical Immunology, 257, 109847. https://doi.org/10.1016/j.clim.2023.109847

Vancouver

Skarlis C, Papadopoulos V, Raftopoulou S, Mavragani CP, Evangelopoulos ME. B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females. Clinical Immunology. 2023;257:109847. doi:10.1016/j.clim.2023.109847

BibTeX
@article{Skarlis2023,
  author = {Skarlis, Charalampos and Papadopoulos, Vassilis and Raftopoulou, Sylvia and Mavragani, Clio P and Evangelopoulos, Maria-Eleftheria},
  title = {B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females},
  journal = {Clinical Immunology},
  year = {2023},
  volume = {257},
  pages = {109847},
  doi = {10.1016/j.clim.2023.109847}
}
Kostenlos starten →